US Patent Issued to BEIJING GRAND JOHAMU PHARMACEUTICAL, NANJING GRITPHARMACo. on Aug. 25 for "Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,861, issued on Aug. 25, was assigned to BEIJING GRAND JOHAMU PHARMACEUTICAL COMPANY LTD. (Bejing, China) and NANJING GRITPHARMACo. LTD. (NanJing, China).

"Crystal form of compound and fumaric acid, pharmaceutical composition and method for treating coronavirus-induced diseases" was invented by Weiye Wei (Beijing), Jiannan Yang (Beijing), Xiaotao Wu (Beijing), Taotao Zhao (Beijing), Hao Wang (Beijing), Chao Li (Beijing), Lei Qu (Beijing) and Bin Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a crystal form comprising a compound of Formula (I) and fumaric acid, wherein the crystal form satisfies at least o...